Log inSign up
Invivyd
905 posts
user avatar
Invivyd
@Invivyd
Invivyd is improving lives with medicines for serious infectious diseases. Pro-human. Anti-virus. Opposed to COVID and spike protein "garbage" in all forms
New Haven, CT
invivyd.com
Joined July 2020
646
Following
2,740
Followers
  • user avatar
    Invivyd
    @Invivyd
    Nov 13, 2025
    Epstein-Barr virus was discovered in 1964. EBV is the original oncovirus, is now strongly implicated as causal in Lupus, demonstrates similar biological features in the etiology of Multiple Sclerosis, and, with learnings still emerging 60+ years after discovery, we have an
    user avatar
    Billy Hanlon
    @bhanlon15
    Nov 13, 2025
    'Stanford Links Lupus to Common Virus' "This is the single most impactful finding to emerge from my lab in my entire career," said William Robinson , MD, PhD, a professor of immunology and rheumatology..."We think it applies to 100% of lupus cases." miragenews.com/stanford-links…
    55K
  • user avatar
    Invivyd
    @Invivyd
    Sep 14, 2025
    Endothelial dysfunction sounds so abstract until you learn enough about the endothelium to realize it is perhaps your most important long-term contributor to being healthy and alive
    user avatar
    David Lingenfelter, PhD
    @dlingenfelter
    Sep 13, 2025
    Months after COVID-19, many people still show signs of blood vessel damage, known as endothelial dysfunction. This hidden issue can quietly increase the risk of long-term heart and vascular disease. gemini.google.com/share/0a1d5984…
    23K
  • user avatar
    Invivyd
    @Invivyd
    Aug 15, 2025
    News: Invivyd aligns with U.S. FDA on rapid pathway to full approval of vaccine alternative monoclonal antibody VYD2311 to protect American adults and adolescents from COVID-19.
    159K
  • user avatar
    Invivyd
    @Invivyd
    Jul 2, 2025
    BREAKING: Anecdotes are wonderful - let’s go get the data! Invivyd & leading researchers launch SPEAR Study Group to explore effects of mAb therapy on people suffering from Long COVID & post-vaccination syndrome. investors.adagiotx.com/news-releases/… @UCSF @polybioRF @MichaelPelusoMD
    investors.invivyd.com
    Investor Overview | Invivyd
    The Investor Relations website contains information about Invivyd's business for stockholders, potential investors, and financial analysts.
    45K
  • user avatar
    Invivyd
    @Invivyd
    Jun 29, 2025
    Monoclonal antibodies: The next frontier in disease prevention | Marc Elia
    From linkedin.com
    305K
  • user avatar
    Invivyd
    @Invivyd
    Aug 18, 2025
    CDC now estimates COVID infections are rising in 34 U.S. states - and declining in zero. Invivyd's latest data: pemivibart as well as next-gen mAb VYD2311 show continued in-vitro neutralizing activity against XFG, the currently dominant SARS-CoV-2 variant. Read more:
    investors.invivyd.com
    Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against...
    New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA ®  (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate...
    205K
  • user avatar
    Invivyd
    @Invivyd
    May 6, 2025
    Replying to @drseanmullen
    We call it a mass disabling event, and we’re all still in it. Nothing to do but keep pushing for more and better protection and treatment for everyone!
    7.5K
  • user avatar
    Invivyd
    @Invivyd
    Jan 3, 2024
    We are pleased to announce that we have requested Emergency Use Authorization from the U.S. FDA for VYD222, a monoclonal antibody candidate, for the pre-exposure prevention of COVID-19 in immunocompromised adults and adolescents. investors.invivyd.com/news-releases/…
    12K
  • user avatar
    Invivyd
    @Invivyd
    Oct 16, 2025
    Joining the large choir of people glad to see this issue getting more attention
    user avatar
    Rolling Stone
    @RollingStone
    Oct 16, 2025
    Long Covid Is Real — And It’s Changing an Entire Generation Hundreds of thousands of kids in America are struggling with an illness that many doctors and schools refuse to recognize.e Feature: rollingstone.com/culture/cultur…
    3.6K
  • user avatar
    Invivyd
    @Invivyd
    Jun 26, 2025
    News from Invivyd this morning: Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection
    investors.invivyd.com
    Invivyd Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19...
    Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate...
    16K
  • user avatar
    Invivyd
    @Invivyd
    Mar 22, 2024
    #BreakingNews: We are delighted to announce that the U.S. FDA has authorized our investigational monoclonal antibody for emergency use. Read our press release to learn more about this important new therapeutic option: investors.invivyd.com/news-releases/…. #SARSCoV2
    00:00
    18K
  • user avatar
    Invivyd
    @Invivyd
    Jul 21, 2025
    Earlier today, Marc Elia shared his reflections on powerful new data on how COVID-19 is impacting patients' cancer care and patient outcomes. People fighting cancer deserve the freedom to focus on their health. Yet for many, COVID-19 is more than “just a virus” - it’s a barrier
    70K
  • user avatar
    Invivyd
    @Invivyd
    Sep 4, 2025
    We are very excited for the coming RECOVER-TLC workshop at which SPEAR representatives Drs. David Putrino @PutrinoLab and Amy Proal @microbeminded2 will discuss our proposal for Long Covid antibody trialing! investors.invivyd.com/news-releases/…
    20K
  • user avatar
    Invivyd
    @Invivyd
    Apr 4, 2024
    We are proud to announce that our investigational monoclonal antibody authorized for emergency use by the U.S. FDA is now available for healthcare providers to order in the U.S. from a network of authorized specialty distributors. Learn more: invivyd.com/more-informati…. #SARSCOV2
    15K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up